Your browser doesn't support javascript.
loading
A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p-formylphenyl)sulphonylurea.
Washio, K; Makaya, O; Sasaki, H; Nishida, K; Nakamura, J; Shibasaki, J.
Affiliation
  • Washio K; School of Pharmaceutical Sciences, Nagasaki University, Japan.
J Pharm Pharmacol ; 45(3): 231-3, 1993 Mar.
Article in En | MEDLINE | ID: mdl-8483106
We investigated the metabolism of tolbutamide by using synthetic 1-butyl-3-(p-formylphenyl)sulphonylurea (ATB), an intermediate in the metabolic pathway of tolbutamide. ATB (40 mg kg-1) administered intravenously to rabbits was oxidized to 1-butyl-3-(p-carboxyphenyl)sulphonylurea (CTB) and also reduced to 1-butyl-3-(p-hydroxymethylphenyl)sulphonylurea (HMTB). Therefore, it is likely that in the metabolism of tolbutamide, the oxidation of HMTB to ATB involved the reverse reaction, suggesting the reduction of ATB to HMTB. The oxidation of ATB to CTB was inhibited by disulfiram pretreatment. ATB was detected in the blood following intravenous administration of HMTB in rabbits pretreated with disulfiram. These results, confirm that ATB is an intermediate in the oxidative metabolism of tolbutamide in the rabbit.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tolbutamide Limits: Animals Language: En Journal: J Pharm Pharmacol Year: 1993 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tolbutamide Limits: Animals Language: En Journal: J Pharm Pharmacol Year: 1993 Document type: Article Affiliation country: Japan Country of publication: United kingdom